Since its inception in 1984, the TIMI Study Group has been an Academic Research Organization dedicated to advancing the knowledge and care of patients suffering from cardiovascular disease. We have led a wide array of trials, from phase I to phase IV, enrolling from less than 30 to more than 26,000 subjects, and with both industry and NIH support. Trials have been conducted in over 50 countries and at more than 5000 separate sites.
We investigate a broad array of therapeutic interventions in individuals across the spectrum of cardiovascular disease, ranging from prevention in those with risk factors, to emergent interventions in those with acute manifestations of disease. In addition, we have used our large database of clinical findings, biomarkers, and genotypes to enhance the understanding of cardiovascular disease and its risk factors.
By leading large-scale, international, randomized controlled trials of novel therapeutics and performing sophisticated analyses, we have been privileged to help shape the very practice of cardiovascular medicine for over a quarter of a century.
Company Details
- Employees
- 51
- Founded
- -
- Address
- Boston, Ma
- Phone
- +1 800-385-4444
- ti****@****ers.org
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- timi.org
- Keywords
- Cardiovascular Clinical Trials.
- HQ
- Boston, MA
Timi Study Group Questions
Timi Study Group's helpline number is +1 800-385-4444
Timi Study Group's website is timi.org
Timi Study Group's LinkedIn profile is https://www.linkedin.com/company/timi-study-group
Timi Study Group has
51 employees.
View email and phone details for 51
employees at Timi Study Group.
Timi Study Group's industry is
Research Services
Timi Study Group's top competitors are
Karyopharm Therapeutics Inc.,
Corbus Pharmaceuticals,
Medicus Healthcare Solutions,
Alcanza Clinical Research,
Baim Institute For Clinical Research,
Evelo Biosciences,
Iqvia,
Checkmate Pharmaceuticals,
Anthos Therapeutics,
Ariad Pharmaceuticals, Inc..
Timi Study Group's support email address is timi@partners.org
Timi Study Group's categories are Research Services
Timi Study Group's founding year is 1985
